ArticleBMC medicine2019

Postmarketing commitments for novel drugs and biologics approved by the US Food and Drug Administration: a cross-sectional analysis.

Joshua D Wallach et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.